Related by context. All words. (Click for frequent words.) 70 neuropsychiatric diseases 66 pathophysiological 66 psychiatric disorders 65 neuroinflammation 65 neurodegenerative diseases 65 neurodegenerative disorders 65 neuronal dysfunction 65 underlying pathophysiology 65 lysosomal storage diseases 65 mitochondrial dysfunction 64 myeloproliferative disorders 64 neurodevelopmental disorders 64 metabolic abnormalities 64 Dysregulation 64 biologic pathways 64 pain syndromes 63 dopamine receptor gene 63 pathophysiologic 63 pathogenic mechanisms 63 Genetic predisposition 63 underlying molecular mechanisms 63 protein misfolding diseases 63 hypothalamic pituitary adrenal axis 63 aetiology 63 obesity insulin resistance 62 synaptic function 62 FTLD 62 astrocytomas 62 causal pathways 62 degenerative neurological diseases 62 mood disorders 62 demyelinating diseases 62 myeloproliferative diseases 62 etiological 62 susceptibility genes 62 mitochondrial disorders 62 progressive neurodegenerative disorder 62 neurological diseases 62 NR2B 62 pathogenetic 62 prostate carcinogenesis 62 PTPN# 62 alexithymia 62 MGUS 62 endophenotypes 61 epilepsies 61 signaling cascades 61 rheumatic diseases 61 renal fibrosis 61 muscular dystrophies 61 neurodegeneration 61 cholesterol metabolism 61 essential thrombocythemia 61 excitotoxicity 61 genetic polymorphism 61 neurologic disorders 61 neuropsychiatric disorder 61 neurological disorders 61 pathophysiological mechanisms 61 pathogenesis 61 genetic loci 61 SMAD4 61 neurocognitive impairment 61 epigenetic alterations 61 myeloproliferative neoplasms 61 fibrotic disease 61 Vitamin D insufficiency 61 metabolic disorders 61 lipid abnormalities 61 neurodegenerative disease 61 gastric carcinoma 61 synaptogenesis 61 neurodevelopmental disorder 61 Genetic variations 61 arterial calcification 61 paraneoplastic 61 ataxias 61 thyroid dysfunction 61 cellular pathways 60 #q#.# [002] 60 amyloid cascade 60 motor neuron degeneration 60 Major depressive disorder 60 neuroendocrine 60 depressive disorders 60 pathological hallmarks 60 ADPKD 60 Inflammatory bowel diseases 60 gastric carcinogenesis 60 V#F mutation 60 motor neuron diseases 60 molecular mechanisms underlying 60 CagA 60 underlying vasculopathy 60 Oxidative damage 60 dysregulated 60 NF1 60 de novo mutations 60 IL#R 60 aetiological 60 neuroanatomical 60 monogenic 60 degenerative disorders 60 chromosomal translocations 60 neuronal plasticity 60 myelofibrosis polycythemia vera 60 Genetic variants 60 depressive illnesses 60 physiologic mechanisms 60 intestinal epithelium 60 Autoimmune disorders 60 neural degeneration 60 hyperprolactinemia 60 cAMP signaling 60 Wernicke Korsakoff syndrome 60 pathophysiology 59 lipoprotein metabolism 59 ciliopathies 59 phenotypes 59 Chronic insomnia 59 airway hyperresponsiveness 59 lymphocyte activation 59 immunopathology 59 non alcoholic steatohepatitis 59 comorbid disorders 59 HGPS 59 proliferative diseases 59 neurocognitive deficits 59 CB2 receptor 59 etiologic 59 pulmonary hypertension PH 59 JAK2 enzyme 59 sporadic ALS 59 cognitive dysfunction 59 Glucocorticoids 59 Neurological disorders 59 predisposing factors 59 neuro degenerative diseases 59 potent inhibitors 59 NKG2D 59 susceptibility gene 59 dysregulation 59 acetylcholine receptor 59 comorbid depression 59 idiopathic pulmonary 59 euthymic patients 59 FMRP protein 59 diabetic microvascular complications 59 cardiac hypertrophy 59 hypovitaminosis D 59 clefting 59 autoinflammatory diseases 59 HeFH 59 biochemical abnormalities 59 neuropathies 59 dopaminergic 59 G6PD deficiency 59 protein misfolding 59 autoimmune inflammatory 59 neuroligins 59 Cognitive impairment 59 apoE 59 hyperinsulinemia 59 airway remodeling 59 oncogenesis 59 mGluR 59 SSc 59 rheumatic disease 59 metabolic abnormality 59 nonalcoholic steatohepatitis 59 apoptotic pathway 59 neurological disorder affecting 59 respiratory viral infections 59 PTEN mutations 59 Autoimmune diseases 59 mtDNA mutations 59 inherited predisposition 59 epigenetic mechanisms 59 Smad3 59 lysosomal storage disease 59 affective disorders 59 hereditary predisposition 59 generalized epilepsy 59 neuropathologic 59 juvenile idiopathic arthritis 59 GABA receptor 59 hypothalamic pituitary 59 pathophysiologic mechanisms 59 medulloblastomas 58 Atypical antipsychotics 58 cognitive deficits 58 molecular abnormalities 58 DQB1 * 58 kidney urologic 58 Clusterin 58 rheumatic disorders 58 Alzheimer Disease AD 58 AUDs 58 p# activation 58 mGluRs 58 neurofibromatosis type 58 Pseudomonas aeruginosa infections 58 FGFs 58 galanin 58 pharmacologic treatments 58 Frontal lobe 58 inherited mutations 58 psychiatric illnesses 58 missense mutations 58 glial tumors 58 gene polymorphisms 58 myelination disorders 58 Neurodegenerative diseases 58 neurite outgrowth 58 immunodeficiencies 58 affective psychoses 58 prenatal exposures 58 transcriptional regulation 58 myopathies 58 Leukemias 58 Comorbid 58 Anxiety disorders 58 gastrointestinal dysfunction 58 intracellular signal transduction 58 mGluR2 NAM 58 epigenetic changes 58 behavioral disinhibition 58 nicotinic acetylcholine receptors 58 autoimmune thyroid 58 anxiety disorders 58 genetic polymorphisms 58 osteoarthritis rheumatoid arthritis 58 lupus scleroderma 58 ERK signaling 58 epigenetic markers 58 Magnesium deficiency 58 Haptoglobin 58 epithelial tumors 58 predisposing factor 58 mitochondrial toxicity 58 γ secretase 58 Epstein Barr Virus EBV 58 COX2 58 neurobiological 58 neuroimaging studies 58 coinfection 58 primary biliary cirrhosis 58 systemic lupus erythematosus 58 PDGF receptor 58 comorbid anxiety 58 Mood disorders 58 renal diseases 58 polyarticular 58 cortical dysplasia 58 NFTs 58 JAK2 58 NF2 58 demyelinating 58 p# mutations 58 proto oncogene 58 microdeletion 58 circadian genes 58 subsyndromal 58 neuroendocrine cancers 58 MECP2 gene 58 TTR amyloidosis 58 neurodevelopment 58 vascular endothelial dysfunction 58 lupus multiple sclerosis 58 familial adenomatous polyposis 58 VIPR2 58 CYT# potent vascular disrupting 58 insulin resistance syndrome 58 adult neurogenesis 58 Apolipoprotein E 58 atherogenesis 58 autoimmune thyroiditis 58 BMP signaling 58 CYP #A# 58 LIS1 58 skeletal muscle weakness 58 PDGFR 58 untreated celiac disease 58 staphylococcal infections 58 Systemic lupus 58 prefrontal regions 58 hepatocellular 58 neurotrophic 58 glutamate receptors 58 neuropathological 57 protein tau 57 JNK pathway 57 IL 1ß 57 neuropsychiatric symptoms 57 familial amyloidotic polyneuropathy FAP 57 myoclonus 57 tryptase 57 lipid metabolism 57 etiologic factors 57 Severe Primary IGFD 57 progranulin 57 epigenetic regulation 57 epilepsy Parkinson disease 57 Myelodysplastic syndromes MDS 57 mGluR5 antagonist 57 neuronal degeneration 57 mutant huntingtin protein 57 olfactory dysfunction 57 metabolic disturbances 57 Atopic dermatitis 57 chronicity 57 neurogenic 57 EBV infection 57 immunoregulation 57 neuronal signaling 57 glutamatergic 57 cardiometabolic disorders 57 disorders 57 etiological factors 57 Parkinson disease Alzheimer disease 57 CNTNAP2 57 aneuploidies 57 familial clustering 57 hypogonadotropic hypogonadism 57 chromosomal rearrangement 57 MAP kinases 57 biochemical mechanisms 57 cholinergic 57 proteoglycan 57 familial pancreatic cancer 57 neural tissues 57 T1DM 57 serotonin receptor 57 axonal degeneration 57 autoimmune diseases 57 c MET 57 Diabetic neuropathy 57 Androgenetic alopecia 57 diabetes dyslipidemia 57 hyperphosphorylation 57 neurodevelopmental 57 psychobiological 57 folate deficiency 57 Hashimoto thyroiditis 57 autosomal dominant 57 NF kB signaling 57 hematopoietic malignancies 57 diabetic nephropathy 57 autonomic dysfunction 57 autosomal dominant disorder 57 phosphatidylinositol 3 57 endocannabinoid signaling 57 caveolin 57 Brain derived neurotrophic 57 spondyloarthritis 57 interleukins 57 tic disorders 57 TLR antagonists 57 Janus kinase 57 basal cell nevus syndrome 57 Sjögren syndrome 57 clinically heterogeneous 57 leukemias lymphomas 57 colorectal carcinogenesis 57 myotonic muscular dystrophy 57 bexarotene 57 developmental abnormalities 57 neurochemistry 57 TNFalpha 57 Hutchinson Gilford progeria 57 neurologic diseases 57 Fas ligand 57 COX enzymes 57 osteosarcomas 57 nucleoside analogues 57 AT1R 57 receptor subtype 57 PsA 57 multiple sclerosis psoriasis 57 atypical hemolytic uremic syndrome 57 inhibitory neurotransmitters 57 synapse formation 57 MELAS 57 fatty acid synthase 57 SLC#A# [002] 57 narcolepsy cataplexy 57 Psoriatic arthritis 57 bone marrow mesenchymal stem 57 monoclonal gammopathy 57 bronchopulmonary dysplasia BPD 57 systemic fungal infections 57 STAT4 57 neoplastic 57 proliferative diabetic retinopathy 57 chromatin remodeling 57 diabetes mellitus DM 57 upregulating 57 cardiolipin 57 pediatric bipolar disorder 57 pathophysiologic mechanism 57 inherited neurological disorder 57 catenin 57 Pathological gambling 57 Dental caries 57 mitogen activated protein kinase 57 CYP #D# 57 CYP#C# [002] 57 p# MAPK 57 neurobiological mechanisms 57 cell signaling pathways 57 metabolic dysfunction 57 ABCB1 57 myotonic dystrophy 57 ALDH2 57 hyperalgesia 57 APOE gene 57 transient receptor 57 hyperparathyroidism 57 progressive neurodegenerative 57 nociceptive pain 57 biochemical imbalances 57 unprovoked seizures 57 allergic inflammation 57 genotoxic stress 57 excitotoxic 57 telomere dysfunction 57 heritable diseases 57 neurexins 57 C1q 57 blood coagulation disorders 57 dietary interventions 56 rheumatoid arthritis multiple sclerosis 56 neuroblastomas 56 Lu AA# 56 IL6 56 IGFBP2 56 antiphospholipid syndrome 56 plasma lipid 56 Froguel 56 potentially modifiable 56 microcephalin 56 PB1 F2 56 melanocortin receptors 56 constipation predominant irritable bowel 56 GRP# 56 lipid disorders 56 receptor subtypes 56 chronic eosinophilic leukemia 56 Angelman syndrome 56 Depressive disorders 56 Tay Sachs thalassemia 56 histone methylation 56 Neurogenesis 56 Oxidative stress 56 receptor agonists 56 genetic determinants 56 epilepsy multiple sclerosis 56 sortilin 56 epithelial cancers 56 somatoform disorders 56 neurodegenerative 56 leukaemias 56 hyperactivation 56 amyloid formation 56 TMEM#B 56 pathophysiological processes 56 psoriasis psoriatic arthritis 56 autism susceptibility genes 56 MAPK pathway 56 nerve degeneration 56 neuro degenerative disorders 56 bone metabolism 56 hereditary hemochromatosis 56 cell adhesion molecules 56 comorbid psychiatric 56 #p#.# [002] 56 macrovascular complications 56 ABCA1 56 Singh Manoux 56 protein tyrosine phosphatases 56 inflammatory bowel diseases 56 neuropathic pain 56 carbohydrate metabolism 56 androgenetic alopecia 56 IL 1β 56 spinocerebellar ataxia 56 NF kB pathway 56 LRRK2 56 Genetic variation 56 neurodegenerative disorder 56 familial ALS 56 imatinib resistance 56 GBA mutations 56 lysosomal storage disorder 56 autoimmune disorders 56 lymphoproliferative disorders 56 cerebral vasospasm 56 presymptomatic 56 mycosis fungoides 56 Leydig cell 56 dissociative disorders 56 cardiac abnormalities 56 Becker muscular dystrophy 56 Rh incompatibility 56 nongenetic 56 inflammatory demyelinating 56 overactivation 56 FLT3 56 neurological abnormalities 56 mediated apoptosis 56 behavioral abnormalities 56 isotypes 56 hematologic disorders 56 gene rearrangements 56 MYCN amplification 56 neurosteroid 56 glucose homeostasis 56 diarrhea predominant irritable 56 mosaicism 56 rheumatologic 56 cardio metabolic 56 ORMDL3 56 tumorigenesis 56 VEGF receptor 56 FGFR2 56 Kv#.# 56 GISTs 56 #beta HSD1 56 generalized seizures 56 microdeletions 56 CYP#D# 56 childhood disintegrative disorder 56 Growth Hormone Deficiency 56 molecular underpinnings 56 neuropsychiatric illnesses 56 leukodystrophies 56 cell adhesion molecule 56 alpha#beta# 56 histone deacetylase 56 neuro developmental disorders 56 pharmacological therapies 56 leukotriene pathway 56 synaptic proteins 56 PI3K pathway 56 leukocyte adhesion 56 #q# [001] 56 erythematosus 56 hippocampal function 56 arrhythmogenic 56 autism spectrum disorders 56 functional polymorphism 56 ADAM# 56 chromosomal instability 56 HPA axis 56 hyperglycaemia 56 Rheumatoid Arthritis RA 56 dyslipidemias 56 CEACAM1 56 myeloproliferative 56 sub syndromal 56 Alzheimers disease 56 hypocalcaemia 56 TCF#L# 56 Periodontitis 56 protein tyrosine phosphatase 56 Chronic inflammation 56 neovascular diseases 56 genomic instability 56 DISC1 gene 56 thrombophilia 56 Alzheimer disease cognitive impairment 56 disorder OCD 56 AAT deficiency 56 tauopathies 56 aberrant activation 56 inherited retinal degeneration 56 epigenetic modification 56 Korsakoff syndrome 56 lichen planus 56 Polyneuropathy 56 microglial cells 56 extrapyramidal symptoms 56 respiratory gastrointestinal 56 hypocretin neurons 56 demyelination 56 dopamine signaling 56 melatonin receptor 56 rheumatoid arthritis lupus 56 hypochondriasis 56 subclinical atherosclerosis 56 testicular tumors 56 isoenzymes 56 DARPP 56 protein kinase C 56 interferon pathway 56 folate metabolism 56 alpha synuclein protein 56 torsade de pointes 56 biogenesis 56 ANCA associated 56 Periodontal disease 56 Notch signaling 56 herpes zoster shingles 56 elevated triglyceride levels 56 neuronal nitric oxide synthase 56 glomerulonephritis 56 PPAR γ 56 Parkinsonian Syndromes 56 axonal damage 56 PI3K Akt 56 2 diabetes T2D 56 SRBD 56 anticonvulsants 56 neuro inflammatory 56 IgA deficiency 56 autoantigen 56 dystrophies 56 PDE#A 56 pathogenetic mechanisms 56 renal scarring 56 von Willebrand disease 56 serine threonine 56 extrapyramidal 56 Six3 56 unknown etiology 56 T2DM 56 regulates gene expression 56 non coding RNA 56 oligomeric 56 pharmacological interventions 56 Bardet Biedl Syndrome 56 neuropsychological impairments 56 bipolar disorder schizophrenia 56 acetabular dysplasia 56 PKU genetic 56 Posttraumatic stress disorder 56 skeletal metastases 56 psychopharmacologic 56 #q# deletion 56 metabolic syndromes 55 COMT 55 SLC#A# gene [002] 55 neurofibromas 55 schizophreniform disorder 55 multisystem disease 55 unipolar depression 55 inflammatory bowel disease 55 retinoid X 55 OPHN1 55 immune dysregulation 55 Mitochondrial diseases 55 morbidities 55 diabetic kidney 55 autoantigens 55 NKX2 55 leukemia ALL 55 neuroinflammatory 55 Obsessive compulsive disorder 55 hematological abnormalities 55 PON1 55 germline mutations 55 Wnt beta catenin 55 pharmacological approaches 55 INF2 55 glutamatergic neurons 55 cMET 55 coagulation cascade 55 Neurofibromatosis type 55 P#X# 55 PKC beta 55 primary hyperparathyroidism 55 tyrosine kinases 55 Wnt signaling pathway 55 myelomas 55 Kufs disease 55 atherosclerotic disease 55 endocrine diseases 55 RNAi therapeutic targeting 55 TNF antagonist 55 glial 55 PC# cells 55 coagulation disorders 55 Celiac sprue 55 Gleevec inhibits 55 CALHM1 55 extrapyramidal symptoms EPS 55 bile acid metabolism 55 systemic lupus erythematosus lupus 55 gastrointestinal disturbances 55 Niemann Pick disease 55 biopsychosocial 55 coronary vasodilation 55 JAK STAT pathway 55 habenula 55 syndromes 55 serine protease 55 biological pathways 55 muscular dystrophy cystic fibrosis 55 atopic eczema 55 primidone 55 dopaminergic therapy 55 liver fibrosis 55 Bronchiectasis 55 neovascularisation 55 atherothrombotic 55 Alzheimer disease AD 55 neurotransmission 55 Neuregulin 1 55 cerebellar 55 Systemic lupus erythematosus SLE 55 HER2 overexpression 55 androgen receptor AR 55 APOE ε4 55 dopamine D2 receptors 55 LPA1 55 dominantly inherited 55 Hypothalamic 55 Mild Cognitive Impairment 55 sJIA 55 impulsive behaviors 55 modulatory 55 p#INK#a 55 genomic variants 55 premenstrual dysphoric disorder PMDD 55 Alzheimer pathology 55 endocrine abnormalities 55 Fibromyalgia Syndrome FMS 55 Flt3 55 TXNIP 55 internalizing disorders 55 DNA methylation patterns 55 thromboembolic disease 55 methylenetetrahydrofolate reductase 55 bipolar illness 55 multifactorial disease 55 diabetes cardiovascular disease 55 VCFS 55 hypereosinophilic syndrome 55 HBV genotypes 55 lipid homeostasis 55 miRs 55 anterior uveitis 55 neurofibrillary tangles 55 podocytes 55 neuronal differentiation 55 granulomatous 55 Peutz Jeghers syndrome 55 heritable disorders 55 DNA demethylation 55 Pervasive Developmental Disorders 55 atopic diseases 55 histone acetylation 55 schizophrenia 55 CP CPPS 55 NOD2 55 pRb 55 micro RNAs 55 diabetic retinopathy DR 55 neurobehavioral disorder 55 recurrent abdominal pain 55 Lafora disease 55 genetic syndromes 55 anticholinergic effects 55 Hypertrophic 55 IKK2 55 kinase PI3K pathway 55 temper dysregulation disorder 55 tissue fibrosis 55 HNPCC 55 ependymomas 55 GABA aminotransferase 55 NAGS deficiency 55 Friedreich Ataxia FRDA 55 chronic periodontitis 55 mediated autoimmune diseases 55 TGF b 55 susceptibility loci 55 thyrotoxicosis 55 cardio renal 55 psychotic disorders 55 CaM kinase II 55 engineered RAP peptides 55 pro angiogenic 55 hormonal abnormalities 55 growth hormone secretion 55 APOE genotype 55 channelopathies 55 eczema asthma 55 atherosclerotic cardiovascular disease 55 cachexia 55 antibody mediated 55 metabolic dysfunctions 55 calcium homeostasis 55 neuropathology 55 FGFR1 55 hormones neurotransmitters 55 phospholipase A2 55 Sezary syndrome 55 nonalcoholic steatohepatitis NASH 55 inflammatory disorders 55 HDAC enzymes 55 selective inhibition 55 JAK2 kinase 55 Crohn disease CD 55 PIK3CA 55 Degenerative diseases 55 herpesviruses 55 Cryptococcus neoformans 55 somatostatin analogs 55 Peripheral neuropathy 55 Chronic lymphocytic leukemia 55 protein kinases 55 multisystemic 55 apoE4 55 enterocolitis 55 melanocortin receptor 55 deacetylation 55 etiology 55 juvenile idiopathic arthritis JIA 55 podocyte 55 neuronal nicotinic receptors NNRs 55 autosomal recessive 55 noradrenergic 55 LHRH antagonists 55 developmental disorders 55 BRAF V#E 55 #q#.# [001] 55 diagnostic biomarker 55 autophagic 55 multidrug resistance 55 post transplant lymphoproliferative 55 Orexin 55 carcinogenesis 55 PTP 1B 55 FASPS 55 cystic fibrosis chronic pancreatitis 55 malignant lymphomas 55 1 diabetes T1D 55 familial hypercholesterolemia FH 55 nAChRs 55 Alessandro Riva 55 carotid atherosclerosis 55 Generalized Anxiety Disorder 55 anterior cingulate gyrus 55 parkinsonism 55 serotonin reuptake inhibitors 55 subependymal giant cell 55 nonbacterial prostatitis 55 SNCA 55 vaso occlusive crisis 55 periodontal infections 55 mGluR2 55 Parkinsons disease 55 ADAMTS# 55 arthritis RA 55 monoamines 55 secondary hyperparathyroidism 55 receptor antagonists 55 nongenetic factors 55 acute leukemias 55 thyrotropin 55 pharmacological treatments 55 Hh 55 alpha synuclein gene 55 Prostatitis 55 TGF beta signaling 55 prothrombotic 55 biologic pathway 55 serotonergic 55 nAChR 55 intercellular communication 55 PCNSL 55 CHRNA5 55 peroxisome proliferator activated 55 TLR4 55 psychopathological symptoms 55 neurological manifestations 55 myalgic encephalomyelitis ME 55 activating mutations 55 drug metabolizing enzymes 55 neuroligin 55 disease NAFLD 55 atopic disorders 55 receptor antagonism 55 nitric oxide synthase 55 induce orthostatic hypotension 55 dorsolateral 55 neurobiological disorders 55 hypercholesterolemia 55 hematologic diseases 55 facial clefts 55 cardiometabolic risk 55 lysosomal 55 cholinergic neurons 55 macrovascular disease 55 serotonin receptors 55 chronic autoimmune disorder 55 costimulatory 55 monogenic disorders 55 LRP5 55 Brugada syndrome 55 nicotinic receptor 55 malarial anemia 55 p#/CBP 55 Multiple sclerosis MS 55 peroxisomal 55 enzymatic pathways 55 Myasthenia gravis 55 neuro degeneration 55 hypoperfusion 55 syndrome FXTAS 55 eotaxin 55 Nicotine dependence 55 Fibroblast Growth Factor Receptor 55 MELAS syndrome 55 idiopathic Parkinson disease 55 neuropathic pain metabolic diseases 55 Nonalcoholic fatty liver 55 complement inhibitor eculizumab 55 Fragile X Syndrome 55 Iron deficiency anemia 55 neuroprotection 55 BRAF gene 55 Mild cognitive impairment 55 JAK inhibitors 55 paraganglioma 55 von Willebrand 55 NOMID 55 tonic clonic seizures 54 inherit predisposition 54 EGFR inhibitors 54 penetrance 54 Diabetic nephropathy 54 kinase inhibition 54 mitochondrial mutations 54 fibrotic disorders 54 cardiac insufficiency 54 hyperhomocysteinemia 54 NR#A# 54 hepatic fibrosis 54 diagnostic biomarkers 54 selective modulator 54 epileptogenic 54 Factor Receptor 54 immuno inflammatory diseases 54 disc degeneration 54 metalloprotease 54 premalignant 54 Viprovex TM 54 androgenic alopecia 54 metabotropic glutamate receptors 54 vascular inflammation 54 unmeasured confounders 54 pharmacologic intervention 54 Fatty liver 54 spinal muscle atrophy 54 cell signaling pathway 54 lupus rheumatoid arthritis 54 inverse agonist 54 astrocytic 54 circadian rhythm disorders 54 GH deficiency 54 phenotypic differences 54 malignant transformation 54 systemic scleroderma 54 onset diabetes mellitus 54 Interpersonal psychotherapy 54 phenotypic variability 54 downregulating 54 FXTAS 54 pseudogout 54 Atopic eczema 54 LRRK2 mutations 54 extramedullary 54 IgG4 54 Treg cell 54 developmental neurotoxicity 54 Cowden syndrome 54 CHD7 54 causative genes 54 hepatic stellate cells 54 compulsive hoarding syndrome 54 KIBRA 54 AhR 54 Meckel Gruber 54 PGRN 54 Chronic pancreatitis 54 pilocytic astrocytomas 54 chromosomal rearrangements 54 tumor suppressor protein 54 hepatocellular carcinoma 54 rare autosomal recessive 54 TNF blocker therapy 54 MLH1 54 lung fibrosis 54 vWD 54 PPARγ 54 Myelofibrosis 54 Primary IGFD